2Y9-17704-21164

3 vaccinations 4 coded responses 31 check-ins 4 free-text entries 3 call cases

Sex: Female
Age at first dose: 26-30
ZIP prefix: 370 / TN
Registered: 2020-12-23

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Possible VAERS report

VAERS ID	Confidence	Score	Runner-up	Shared symptoms	Dose	State	VAERS vaccinated / onset / received	Call case
2367464 (opens in a new window)	high	9 / 11	—	2 of 13 VAERS symptoms	same dose (3)	TN matches	2022-01-11 / 2022-04-01 / 2022-07-13 received the same day as the last call	case 849078

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-22
Dose 1 — Pfizer-BioNTech
2020-12-23
Registered in v-safe
2020-12-23
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Headache, Fatigue or tiredness

Adult check-in
2020-12-24
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2020-12-25
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-26
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-27
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-28
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-30
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-01-06
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-11
Dose 2 — Pfizer-BioNTech
2021-01-12
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-01-12
Report sent to call center — days 1–6 daily, dose 2
Be unable to do your normal daily activities

1 call case(s)
2021-01-14
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-01-15
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-19
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-01-27
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-01
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-08
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-02-15
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-02-24
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-04-14
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-07-12
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2022-01-11
Dose 3 — Pfizer-BioNTech
2022-01-11
Survey response — 12 months, dose 2
MedDRA: Pregnancy — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Pregnant

MedDRA releases: 2024-11 · check-in free text available
2022-01-11
Report sent to call center — 12 months, dose 2
Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-01-12
Survey response — days 1–6 daily, dose 3
MedDRA: Nasal congestion — Feeling: Fair · Fatigue or tiredness

Free text: nasal congestion

MedDRA releases: 2024-11 · check-in free text available
2022-01-13
Call 1 — Left Voicemail
2022-01-14
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2022-01-15
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Headache, Fatigue or tiredness

Adult check-in
2022-01-16
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · None

Adult check-in
2022-01-17
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2022-01-18
Health check-in — day 7, dose 3
Feeling: Good · None

Adult check-in
2022-01-25
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2022-02-01
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2022-02-22
Survey response — day 42, dose 3
MedDRA: Hyposmia, Nasal congestion — Feeling: Good

Free text: Some loss of smell, nasal congestion

MedDRA releases: 2024-11 · check-in free text available
2022-07-12
Survey response — 6 months, dose 3
MedDRA: COVID-19, Pre-eclampsia, Premature delivery — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Hospitalization

Free text: #1) Developed pre-eclampsia with severe features with the delivery of my baby happening 2.5 weeks early. #2) Currently have COVID-19 infection.

MedDRA releases: 2024-11 · check-in free text available
2022-07-12
Report sent to call center — 6 months, dose 3
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

Hospitalization · 1 call case(s)
2022-07-13
Call successful
Completed over the phone
2022-07-13
Call successful
Completed over the phone
2023-01-11
Health check-in — 12 months, dose 3
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-22	Pfizer-BioNTech
2	2021-01-11	Pfizer-BioNTech
3	2022-01-11	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2021-01-12	priority 2/3
2022-01-11	Successful 2022-07-13	Completed over the phone
2022-07-12	Successful 2022-07-13	Completed over the phone

Free text

Release 10 — 12 months, dose 2

2022-01-11

Symptoms: Pregnant

Release 10 — days 1–6 daily, dose 3

2022-01-12

Systemic reaction (other): nasal congestion

Release 11 — day 42, dose 3

2022-02-22

Symptoms: Some loss of smell, nasal congestion

Release 12 — 6 months, dose 3

2022-07-12

Symptoms: #1) Developed pre-eclampsia with severe features with the delivery of my baby happening 2.5 weeks early. #2) Currently have COVID-19 infection.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	COVID-19	·	·	✓
SD	Hyposmia	·	·	✓
SD	Nasal congestion	·	·	✓
SD	Pre-eclampsia	·	·	✓
SD	Pregnancy	·	·	✓
SD	Premature delivery	·	·	✓
SRO	Nasal congestion	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release